Editorial
Clinical and regulatory implications of the cardiac arrhythmia suppression trial

https://doi.org/10.1016/0002-9149(90)90034-XGet rights and content

References (8)

There are more references available in the full text version of this article.

Cited by (30)

  • Atrial fibrillation: New management strategies

    1993, Current Problems in Cardiology
View all citing articles on Scopus

The authors are members of the Cardiovascular and Renal Drugs Advisory Board to the Food and Drug Administration.

View full text